Skip to content
Cryos Bio Labs
Investigational compound

Cellular & longevity research

SS-31 / Elamipretide

An investigational peptide studied for interaction with mitochondrial membranes and bioenergetic function.

SS-31 / Elamipretide10 mg Add a Featured Image in WordPress to replace this product placeholder.
ClassificationMitochondria-targeting tetrapeptide
Catalogue strength10 mg
Current contextInvestigational compound
01

What it is

An investigational peptide studied for interaction with mitochondrial membranes and bioenergetic function.

Its catalogue classification is mitochondria-targeting tetrapeptide. Status and formulation matter: a research-labelled vial is not automatically equivalent to an authorized prescription medicine containing a similarly named ingredient.

02

What it is studied or used for

  • Mitochondrial membrane biology
  • Cellular energetics
  • Oxidative-stress models

A research topic is not proof of a health benefit. Evidence can range from cell and animal models to controlled human trials, and those levels should not be treated as equivalent.

03

How it is used or administered

Human administration should occur only inside an authorized clinical trial or under an approved expanded-access pathway. Research vials are not substitutes for trial medication.

04

Dosing context for men and women

For men

No approved routine dose exists for men. Trial protocols determine eligibility, formulation and dose.

For women

No approved routine dose exists for women. Trial protocols determine eligibility, formulation and dose.

Why no universal number? Dose depends on the exact formulation, legal status, indication, concentration, patient factors and monitoring. Publishing a single male or female number would be misleading and unsafe.

05

Active shelf life and storage

Shelf-life rule

Use the lot-specific expiry and storage documentation. Investigational formulations may not share the stability profile of products used in published trials.

Storage

Follow the vial label, certificate of analysis and validated protocol. Do not extrapolate storage after reconstitution from a different formulation.

06

What it may be paired with

Combination use has not been established for routine care and may alter safety or trial eligibility.

Safety boundary

Investigational status means safety, effectiveness and long-term risks remain under study.

07

Continue with primary sources

Evidence and regulatory status change. Verify the exact active ingredient, formulation and jurisdiction before drawing conclusions.

Product availability

Ready to leave the education library?

Purchasing, pricing, shipping and product-specific lot information are handled on the main Cryos Bio Labs website.

View SS-31 / Elamipretide on the main site ↗